Response to Spellberg and Brass

Affiliations

¹ Department of Surgery, University of Cincinnati College of Medicine, Ohio.
² Clinical Research, Merck Research Laboratories, Lexington, Massachusetts.
³ Department of General, Visceral and Thoracic Surgery, Klinikum Peine Academic Hospital of Medical University, Germany.

Comment

Joseph S Solomkin et al. Clin Infect Dis. 2016.

. 2016 Feb 15;62(4):526.

doi: 10.1093/cid/civ896. Epub 2015 Oct 20.

¹ Department of Surgery, University of Cincinnati College of Medicine, Ohio.
² Clinical Research, Merck Research Laboratories, Lexington, Massachusetts.
³ Department of General, Visceral and Thoracic Surgery, Klinikum Peine Academic Hospital of Medical University, Germany.

No abstract available

Comment on

Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).
Solomkin J, Hershberger E, Miller B, Popejoy M, Friedland I, Steenbergen J, Yoon M, Collins S, Yuan G, Barie PS, Eckmann C. Solomkin J, et al. Clin Infect Dis. 2015 May 15;60(10):1462-71. doi: 10.1093/cid/civ097. Epub 2015 Feb 10. Clin Infect Dis. 2015. PMID: 25670823 Free PMC article. Clinical Trial.
Noninferiority Doesn't Mean Not Inferior.
Spellberg B, Brass EP. Spellberg B, et al. Clin Infect Dis. 2016 Feb 15;62(4):525-6. doi: 10.1093/cid/civ895. Epub 2015 Oct 20. Clin Infect Dis. 2016. PMID: 26486703 No abstract available.